Published in J Neurosci on May 01, 1998
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A (2006) 2.04
Mechanisms of gender-linked ischemic brain injury. Restor Neurol Neurosci (2009) 1.24
Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Natl Acad Sci U S A (2001) 1.21
Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health (Lond Engl) (2009) 1.16
Chronic oral estrogen affects memory and neurochemistry in middle-aged female mice. Behav Neurosci (2004) 1.10
Low doses of 17alpha-estradiol and 17beta-estradiol facilitate, whereas higher doses of estrone and 17alpha- and 17beta-estradiol impair, contextual fear conditioning in adult female rats. Neuropsychopharmacology (2010) 1.05
Normal genetic variation, cognition, and aging. Behav Cogn Neurosci Rev (2003) 1.04
Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci U S A (2006) 1.03
Sex and gender differences in the causes of dementia: a narrative review. Maturitas (2014) 1.00
Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline. Neurobiol Aging (2010) 1.00
Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use. PLoS One (2013) 0.98
Sex steroids and the dentate gyrus. Prog Brain Res (2007) 0.96
The effects of acute 17beta-estradiol treatment on gene expression in the young female mouse hippocampus. Neurobiol Learn Mem (2008) 0.94
Differential effects of acute progesterone administration on spatial and object memory in middle-aged and aged female C57BL/6 mice. Horm Behav (2008) 0.93
Building a better hormone therapy? How understanding the rapid effects of sex steroid hormones could lead to new therapeutics for age-related memory decline. Behav Neurosci (2012) 0.92
The prediction and prevention of Alzheimer's disease--towards a research agenda. J Psychiatry Neurosci (1999) 0.90
Age increase of estrogen receptor-α (ERα) in cortical astrocytes impairs neurotrophic support in male and female rats. Endocrinology (2013) 0.88
The effect of hormone therapy on olfactory sensitivity is dependent on apolipoprotein E genotype. Horm Behav (2008) 0.88
The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers. BMC Neurosci (2009) 0.88
Function and comorbidities of apolipoprotein e in Alzheimer's disease. Int J Alzheimers Dis (2011) 0.87
The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease. J Med Genet (2004) 0.84
Effects of long-term treatment with estrogen and medroxyprogesterone acetate on synapse number in the medial prefrontal cortex of aged female rats. Menopause (2012) 0.80
Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease. Am J Transl Res (2009) 0.79
Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE {varepsilon}4 carriers: a case-control study. BMJ Open (2013) 0.78
Acute responses to estradiol replacement in the olfactory system of apoE-deficient and wild-type mice. Brain Res (2010) 0.77
Impact of apoE deficiency during synaptic remodeling in the mouse olfactory bulb. Neurosci Lett (2008) 0.77
Impact of continuous versus discontinuous progesterone on estradiol regulation of neuron viability and sprouting after entorhinal cortex lesion in female rats. Endocrinology (2014) 0.76
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis. J Res Med Sci (2011) 0.76
Regional-specific effects of ovarian hormone loss on synaptic plasticity in adult human APOE targeted replacement mice. PLoS One (2014) 0.76
Gonadal steroids do not affect apolipoprotein E expression in aging mouse cerebral cortex. Cell Mol Neurobiol (2010) 0.76
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci (2001) 4.92
Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science (1997) 4.26
A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. Biol Reprod (1982) 3.28
Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci (1990) 2.95
Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol (1995) 2.33
Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem (2001) 2.14
Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron (1990) 2.09
Extensive postmortem stability of RNA from rat and human brain. J Neurosci Res (1986) 1.58
Longitudinal studies of estrous cyclicity in aging C57BL/6J mice: II. Cessation of cyclicity and the duration of persistent vaginal cornification. Biol Reprod (1984) 1.56
Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res Mol Brain Res (1995) 1.50
Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol (1995) 1.49
Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. J Biol Chem (2001) 1.49
Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res (1991) 1.39
Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends Neurosci (1992) 1.39
Loss of lipid during fixation for electron microscopy. J Cell Biol (1967) 1.38
Imminent oocyte exhaustion and reduced follicular recruitment mark the transition to acyclicity in aging C57BL/6J mice. Biol Reprod (1983) 1.35
GFAP mRNA increases with age in rat and human brain. Neurobiol Aging (1994) 1.31
Research opportunities for medical students: an approach to the physician-investigator shortage. J Med Educ (1980) 1.29
Early cohort mortality predicts the rate of aging in the cohort: a historical analysis. J Dev Orig Health Dis (2012) 1.26
Catecholamine metabolism in the brains of ageing male mice. Brain Res (1973) 1.24
Differential contributions of ovarian and extraovarian factors to age-related reductions in plasma estradiol and progesterone during the estrous cycle of C57BL/6J mice. Endocrinology (1992) 1.22
TGF-beta 1 is an organizer of responses to neurodegeneration. J Cell Biochem (1993) 1.22
Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging (1998) 1.21
Purification and characterization of brain clusterin. Biochem Biophys Res Commun (1994) 1.21
Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord (2000) 1.21
Complement activation in very early Alzheimer disease. Alzheimer Dis Assoc Disord (2005) 1.18
Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol (1997) 1.17
Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol Reprod (1981) 1.16
Alterations in pulmonary surface active lipids during exposure to increased oxygen tension. J Clin Invest (1965) 1.15
Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science (1990) 1.15
Ovarian and steroidal influences on neuroendocrine aging processes in female rodents. Endocr Rev (1984) 1.14
Anti-inflammatory mechanisms of dietary restriction in slowing aging processes. Interdiscip Top Gerontol (2007) 1.13
Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol Dis (1996) 1.10
Comparison of the composition and surface activity of "alveolar" and whole lung lipids in the dog. Biochim Biophys Acta (1965) 1.08
The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience (1999) 1.06
Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol Aging (1993) 1.05
Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exp Neurol (1988) 1.03
LHRH neurons in the female C57BL/6J mouse brain during reproductive aging: no loss up to middle age. Neurobiol Aging (1986) 1.02
Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience (1994) 1.02
Age-correlated loss of dopaminergic binding sites in human basal ganglia. J Neurochem (1982) 1.02
Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol Aging (1991) 1.02
NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2. Brain Res (1997) 1.01
Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol (1994) 1.01
Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. Endocrinology (1998) 1.00
The use of ammonium acetate in the precipitation of ribonucleic acid. Biochem J (1975) 1.00
Glial fibrillary acidic protein transcription responses to transforming growth factor-beta1 and interleukin-1beta are mediated by a nuclear factor-1-like site in the near-upstream promoter. J Neurochem (1999) 1.00
Reproductive senescence in female C57BL/6J mice: ovarian impairments and neuroendocrine impairments that are partially reversible and delayable by ovariectomy. Endocrinology (1984) 1.00
The regulation of physiological changes during mammalian aging. Q Rev Biol (1976) 0.99
Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease. J Am Geriatr Soc (1987) 0.99
Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus. Exp Neurol (1999) 0.99
Learning induces a CDC2-related protein kinase, KKIAMRE. J Neurosci (1999) 0.98
Regulation of an Arabidopsis oleosin gene promoter in transgenic Brassica napus. Plant Mol Biol (1994) 0.97
Castration enhances expression of glial fibrillary acidic protein and sulfated glycoprotein-2 in the intact and lesion-altered hippocampus of the adult male rat. Mol Endocrinol (1990) 0.96
Plasma testosterone levels in C57BL/6J male mice: effects of age and disease. Acta Endocrinol (Copenh) (1975) 0.96
Induction of noncatalytic TrkB neurotrophin receptors during axonal sprouting in the adult hippocampus. J Neurosci (1993) 0.96
Middle age: an evolving frontier in gerontology. Neurobiol Aging (1991) 0.96
Increases of glial fibrillary acidic protein in the aging female mouse brain. Neurobiol Aging (1995) 0.96
Increased transcription of the astrocyte gene GFAP during middle-age is attenuated by food restriction: implications for the role of oxidative stress. Free Radic Biol Med (1997) 0.95
TGF-beta 1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp Neurol (1993) 0.95
The glucocorticoid paradox of caloric restriction in slowing brain aging. Neurobiol Aging (2002) 0.94
Transforming growth factor beta 1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localization. Neuroscience (1993) 0.93
Effective oral administration of 17 beta-estradiol to female C57BL/6J mice through the drinking water. Biol Reprod (1986) 0.93
Ageing and the regulation of cell activities during exposure to cold. J Gen Physiol (1969) 0.93
Reversible inactivation of superoxide-sensitive aconitase in Abeta1-42-treated neuronal cell lines. J Neurochem (2000) 0.93
Sequence complexity of polyadenylated RNA obtained from rat brain regions and cultured rat cells of neural origin. Biochemistry (1978) 0.92
Neuroendocrine and pharmacological manipulations to assess how caloric restriction increases life span. J Gerontol A Biol Sci Med Sci (2001) 0.92
Proliferative serous tumors of the ovary. Histologic features and prognosis. Am J Surg Pathol (1978) 0.91
Aging and the regulation of luteinizing hormone in C57BL/6J mice: impaired elevations after ovariectomy and spontaneous elevations at advanced ages. Biol Reprod (1983) 0.91
Reproductive aging in C57BL/6J mice: plasma progesterone, viable embryos and resorption frequency throughout pregnancy. Biol Reprod (1979) 0.91
The role of M.D.-Ph.D. training in increasing the supply of physician-scientists. N Engl J Med (1981) 0.91
Restoration of ovulatory cycles by young ovarian grafts in aging mice: potentiation by long-term ovariectomy decreases with age. Proc Natl Acad Sci U S A (1983) 0.91
The outlook for academic medicine. Bull N Y Acad Med (1980) 0.90
Transforming growth factor-beta 1 induces neuronal and astrocyte genes: tubulin alpha 1, glial fibrillary acidic protein and clusterin. Neuroscience (1994) 0.90
Pulmonary surfactant. N Engl J Med (1971) 0.90
Hematologic and serum electrolyte values of the C57BL-6J male mouse in maturity and senescence. Lab Anim Sci (1973) 0.90
Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J Comp Neurol (1994) 0.89
Age-correlated and ovary-dependent changes in relationships between plasma estradiol and luteinizing hormone, prolactin, and growth hormone in female C57BL/6J mice. Endocrinology (1985) 0.89
Pituitary lactotrope expresses transforming growth factor beta (TGF beta) type II receptor mRNA and protein and contains 125I-TGF beta 1 binding sites. J Endocrinol (1996) 0.89